3.2.1.111: 1,3-alpha-L-fucosidase
This is an abbreviated version!
For detailed information about 1,3-alpha-L-fucosidase, go to the full flat file.
Word Map on EC 3.2.1.111
-
3.2.1.111
-
transfucosylation
-
oligosaccharides
-
lacto-n-tetraose
-
fucosylated
-
perfringens
-
3.2.1.51
-
lacto-n-fucopentaose
-
milk
-
glycoside
-
glycomics
-
infant
-
3-fucosyllactose
- 3.2.1.111
-
transfucosylation
- oligosaccharides
- lacto-n-tetraose
-
fucosylated
- perfringens
-
3.2.1.51
- lacto-n-fucopentaose
- milk
- glycoside
-
glycomics
- infant
- 3-fucosyllactose
Reaction
Synonyms
AfcB, almond emulsin fucosidase I, alpha(1,3/4)-transfucosidase, alpha-1,3/4-L-fucosidase, alpha-L-fucosidase I, alphafuc, BbAfcB, cFase I, core fucosidase I, CpAfc2, fucosidase, 1,3-alpha-L-
ECTree
Advanced search results
Engineering
Engineering on EC 3.2.1.111 - 1,3-alpha-L-fucosidase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
F34H/L321P
the mutant exhibits increased transfucosylation activity compared to the wild type enzyme
F34I/L321P
the mutant exhibits increased transfucosylation activity compared to the wild type enzyme
F34Y/L321P
the mutant exhibits increased transfucosylation activity compared to the wild type enzyme
L321P
the mutant exhibits increased transfucosylation activity compared to the wild type enzyme
F34H/L321P
-
the mutant exhibits increased transfucosylation activity compared to the wild type enzyme
-
F34I/L321P
-
the mutant exhibits increased transfucosylation activity compared to the wild type enzyme
-
F34Y/L321P
-
the mutant exhibits increased transfucosylation activity compared to the wild type enzyme
-
L321P
-
the mutant exhibits increased transfucosylation activity compared to the wild type enzyme
-
249DELTA265
-
the mutant shows decreased activity with 4-nitrophenyl alpha-L-fucoside (14fold) 3-fucosyllactose (5fold) and Lewis X trisaccharide (9fold) compared to the wild type enzyme
C317A
-
the mutant shows decreased activity with 4-nitrophenyl alpha-L-fucoside (9fold) 3-fucosyllactose (4fold) and Lewis X trisaccharide (6fold) compared to the wild type enzyme
C317S
-
the mutant shows decreased activity with 4-nitrophenyl alpha-L-fucoside (2fold) 3-fucosyllactose (3fold) and Lewis X trisaccharide (2fold) compared to the wild type enzyme
C467S
-
the mutant shows decreased activity with 4-nitrophenyl alpha-L-fucoside (0.9fold) 3-fucosyllactose (0.9fold) and Lewis X trisaccharide (9fold) compared to the wild type enzyme
C73S
-
the mutant shows wild type activity with 4-nitrophenyl alpha-L-fucoside and Lewis X trisaccharide and shows decreased activity with 3-fucosyllactose (2fold) compared to the wild type enzyme
D242A
-
the mutant is inactive with 3-fucosyllactose and shows decreased activity with 4-nitrophenyl alpha-L-fucoside (10000fold) and Lewis X trisaccharide (1928fold) compared to the wild type enzyme
E302A
-
the mutant is inactive with 3-fucosyllactose and shows decreased activity with 4-nitrophenyl alpha-L-fucoside (736fold) and Lewis X trisaccharide (900fold) compared to the wild type enzyme
E315A
-
the mutant is inactive with 4-nitrophenyl alpha-L-fucoside and shows decreased activity with 3-fucosyllactose (473fold) and Lewis X trisaccharide (585fold) compared to the wild type enzyme
C317S
-
the mutant shows decreased activity with 4-nitrophenyl alpha-L-fucoside (2fold) 3-fucosyllactose (3fold) and Lewis X trisaccharide (2fold) compared to the wild type enzyme
-
C73S
-
the mutant shows wild type activity with 4-nitrophenyl alpha-L-fucoside and Lewis X trisaccharide and shows decreased activity with 3-fucosyllactose (2fold) compared to the wild type enzyme
-
D242A
-
the mutant is inactive with 3-fucosyllactose and shows decreased activity with 4-nitrophenyl alpha-L-fucoside (10000fold) and Lewis X trisaccharide (1928fold) compared to the wild type enzyme
-
E302A
-
the mutant is inactive with 3-fucosyllactose and shows decreased activity with 4-nitrophenyl alpha-L-fucoside (736fold) and Lewis X trisaccharide (900fold) compared to the wild type enzyme
-
E315A
-
the mutant is inactive with 4-nitrophenyl alpha-L-fucoside and shows decreased activity with 3-fucosyllactose (473fold) and Lewis X trisaccharide (585fold) compared to the wild type enzyme
-
additional information
-
introduction of afcB gene into the Bacterioides longum 105-A strain, which has no intrinsic alpha-L-fucosidase. The transformant is able to utilize 3-fucosyllactose and lacto-N-fucopentaose II as the sole carbon source
additional information
replacement of a 23 amino acids long alpha-helical loop close to the active site of alpha-1,3/4-L-fucosidase from Bifidobacterium bifidum with the corresponding 17-amino acid alpha-helical loop of alpha-1,3/4-L-fucosidase from Clostridium perfringens results in almost complete abolishment of the hydrolytic activity on 3-fucosyllactose (6000 times lower hydrolytic activity than wild-type enzyme from Bifidobacterium bifidum), while the transfucosylation activity is lowered one order of magnitude. The loop engineering results in an alpha-1,3/4-L-fucosidase with transfucosylation activity reaching molar yields of lacto-N-fucopentaose II of 39% on 3-fucosyllactose and negligible product hydrolysis. This is almost 3times higher than the yield obtained with wild-type enzyme from Bifidobacterium bifidum (14%) and comparable to that obtained with alpha-1,3/4-L-fucosidase from Clostridium perfringens (50%)
additional information
-
replacement of a 23 amino acids long alpha-helical loop close to the active site of alpha-1,3/4-L-fucosidase from Bifidobacterium bifidum with the corresponding 17-amino acid alpha-helical loop of alpha-1,3/4-L-fucosidase from Clostridium perfringens results in almost complete abolishment of the hydrolytic activity on 3-fucosyllactose (6000 times lower hydrolytic activity than wild-type enzyme from Bifidobacterium bifidum), while the transfucosylation activity is lowered one order of magnitude. The loop engineering results in an alpha-1,3/4-L-fucosidase with transfucosylation activity reaching molar yields of lacto-N-fucopentaose II of 39% on 3-fucosyllactose and negligible product hydrolysis. This is almost 3times higher than the yield obtained with wild-type enzyme from Bifidobacterium bifidum (14%) and comparable to that obtained with alpha-1,3/4-L-fucosidase from Clostridium perfringens (50%)
additional information
replacement of a 23 amino acids long alpha-helical loop close to the active site of alpha-1,3/4-L-fucosidase from Bifidobacterium bifidum with the corresponding 17-amino acid alpha-helical loop of alpha-1,3/4-L-fucosidase from Clostridium perfringens results in almost complete abolishment of the hydrolytic activity on 3-fucosyllactose (6000 times lower hydrolytic activity than wild-type enzyme from Bifidobacterium bifidum), while the transfucosylation activity is lowered one order of magnitude. The loop engineering results in an alpha-1,3/4-L-fucosidase with transfucosylation activity reaching molar yields of lacto-N-fucopentaose II of 39% on 3-fucosyllactose and negligible product hydrolysis. This is almost 3times higher than the yield obtained with wild-type enzyme from Bifidobacterium bifidum (14%) and comparable to that obtained with alpha-1,3/4-L-fucosidase from Clostridium perfringens (50%)
additional information
-
replacement of a 23 amino acids long alpha-helical loop close to the active site of alpha-1,3/4-L-fucosidase from Bifidobacterium bifidum with the corresponding 17-amino acid alpha-helical loop of alpha-1,3/4-L-fucosidase from Clostridium perfringens results in almost complete abolishment of the hydrolytic activity on 3-fucosyllactose (6000 times lower hydrolytic activity than wild-type enzyme from Bifidobacterium bifidum), while the transfucosylation activity is lowered one order of magnitude. The loop engineering results in an alpha-1,3/4-L-fucosidase with transfucosylation activity reaching molar yields of lacto-N-fucopentaose II of 39% on 3-fucosyllactose and negligible product hydrolysis. This is almost 3times higher than the yield obtained with wild-type enzyme from Bifidobacterium bifidum (14%) and comparable to that obtained with alpha-1,3/4-L-fucosidase from Clostridium perfringens (50%)